Differential forms of p53 in medulloblastoma primary tumors, cell lines and xenografts

被引:10
|
作者
Philipova, Tzvetomira [1 ]
Baryawno, Ninib [2 ]
Hartmann, Wolfgang [4 ]
Pietsch, Torsten [5 ]
Drud, Henrik [3 ]
Johnsen, John Inge [2 ]
Ekstrom, Tomas J. [1 ]
机构
[1] Karolinska Inst, Karolinska Univ Hosp, Ctr Mol Med, Dept Clin Neurosci, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Childhood Canc Res Unit, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden
[3] Karolinska Inst, Dept Oncol Pathol, S-17176 Stockholm, Sweden
[4] Univ Bonn, Med Ctr, Dept Pathol, D-53127 Bonn, Germany
[5] Univ Bonn, Med Ctr, Dept Neuropathol, D-53127 Bonn, Germany
关键词
medulloblastoma; p53; N-terminus; isoforms; Western blot analysis; TRANSCRIPTIONAL ACTIVITY; DISEASE RISK; ESTABLISHMENT; ISOFORMS; STRATIFICATION; LOCALIZATION; EXPRESSION; INDUCTION; PROGNOSIS; APOPTOSIS;
D O I
10.3892/ijo.2010.884
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Medulloblastoma is the most common malignant brain tumor in childhood. The most prevalent chromosomal abnormalities are isochromosome 17q and loss of 17p, the location, of the tumor suppressor gene p53. Mutations in the p53 gene in medulloblastoma are relatively infrequent but have recently been correlated to poor prognosis. Furthermore, the p53 gene encodes nine different isoforms, which may have a profound impact on p53 tumor suppressor activity. Nine medulloblastoma primary biopsy samples, six cell lines from medulloblastoma, and one from a supratentorial PNET, and a medulloblastoma xenograft, along with human brain and visceral tissues, were analyzed by Western blotting, using monoclonal p53 antibodies against two regions in the N-terminus or the central domain. Medulloblastoma primary tissue and xenografts present low molecular weight proteins recognized by both N-terminal p53 antibodies that are absent in all cell lines including the one used for xenografts. Normal visceral organs display short forms of p53, and low levels of canonical p53. Normal brain structures, including cerebellum, contained only canonical size p53 at high levels. In conclusion, our results indicate that the presence of p53 isoforms may play a functional role in medulloblastoma. The observed differences in their presence in cell lines and derived xenografts, suggest that p53 should be investigated in in vivo models rather than in cell lines.
引用
收藏
页码:843 / 849
页数:7
相关论文
共 50 条
  • [21] Differential p53, p21, mdm2 and Rb regulation in glioma cell lines that overexpress wild-type p53
    Pykett, MJ
    Azzam, E
    Dahlberg, W
    Little, JB
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1998, 13 (02) : 213 - 216
  • [22] The role of p53 isoforms' expression and p53 mutation status in renal cell cancer prognosis
    Florijan, Marijana Knezovic
    Ozretic, Petar
    Bujak, Maro
    Pezze, Laura
    Ciribilli, Yari
    Kastelan, Zeljko
    Slade, Neda
    Hudolin, Tvrtko
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (09) : 578.e1 - 578.e10
  • [23] P53 MUTATIONS IN MATCHED PRIMARY AND METASTATIC HUMAN TUMORS
    PELLER, S
    HALEVY, A
    SLUTZKI, S
    KOPILOVA, Y
    ROTTER, V
    MOLECULAR CARCINOGENESIS, 1995, 13 (03) : 166 - 172
  • [24] DDP-induced cytotoxicity is not influenced by p53 in nine human ovarian cancer cell lines with different p53 status
    DeFeudis, P
    Debernardis, D
    Beccaglia, P
    Valenti, M
    Sire, EG
    Arzani, D
    Stanzione, S
    Parodi, S
    DIncalci, M
    Russo, P
    Broggini, M
    BRITISH JOURNAL OF CANCER, 1997, 76 (04) : 474 - 479
  • [25] PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines
    Izetti, Patricia
    Hautefeuille, Agnes
    Abujamra, Ana Lucia
    de Farias, Caroline Brunetto
    Giacomazzi, Juliana
    Alemar, Barbara
    Lenz, Guido
    Roesler, Rafael
    Schwartsmann, Gilberto
    Osvaldt, Alessandro Bersch
    Hainaut, Pierre
    Ashton-Prolla, Patricia
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (05) : 783 - 794
  • [26] Analysis of p53 and miRNA Expression after Irradiation of Glioblastoma Cell Lines
    Sasaki, Akiko
    Udaka, Yuko
    Tsunoda, Yuko
    Yamamoto, Gou
    Tsuji, Mayumi
    Oyamada, Hideto
    Oguchi, Katsuji
    Mizutani, Tohru
    ANTICANCER RESEARCH, 2012, 32 (11) : 4709 - 4713
  • [27] A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin
    H-J Tang
    D Qian
    V K Sondak
    S Stachura
    J Lin
    British Journal of Cancer, 2004, 90 : 1285 - 1292
  • [28] A modified p53 enhances apoptosis in sarcoma cell lines mediated by doxorubicin
    Tang, HJ
    Qian, D
    Sondak, VK
    Stachura, S
    Lin, J
    BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1285 - 1292
  • [29] Expression profiles of p53/p73, NME and GLI families in metastatic melanoma tissue and cell lines
    Ozretic, Petar
    Hanzic, Nikolina
    Proust, Bastien
    Sabol, Maja
    Trnski, Diana
    Radic, Martina
    Musani, Vesna
    Ciribilli, Yari
    Milas, Ivan
    Puljiz, Zvonimir
    Bosnar, Maja Herak
    Levanat, Sonja
    Slade, Neda
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [30] p53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines
    Taylor, AC
    Shu, LL
    Danks, MK
    Poquette, CA
    Shetty, S
    Thayer, MJ
    Houghton, PJ
    Harris, LC
    MEDICAL AND PEDIATRIC ONCOLOGY, 2000, 35 (02): : 96 - 103